Table 2.
EV-miRNA as a drug delivery system in HNSCC.
EV-miRNA | Loading Method | Donor Cell | Recipient Cell | EVs Isolation Method | miRNA Detection Method | Target | Effect | Ref. |
---|---|---|---|---|---|---|---|---|
miR-138 | Lentiviral infection | γδ T cell | OSCC | Ultracentrifugation and precipitation | qRT-PCR | CTLA-4 and PD-1 | Inhibition of cell proliferation and tumor growth | [109] |
miR-185 | miRNA-transfection | MSCs | OPMDs | Magnetic beads capturing | Microarray and qRT-PCR | AKT | Inhibition of inflammation and induction of apoptosis | [110] |
Abbreviations: CTLA-4, cytotoxic T-lymphocyte-associated antigen 4; MSC, mesenchymal stromal cell; OPMD, oral potentially malignant disorders; OSCC, oral squamous cell carcinoma; PD-1, programmed cell death 1.